STOCK TITAN

Varex Imaging Corp - VREX STOCK NEWS

Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.

Company Overview

Varex Imaging Corp is the world's largest independent supplier of x-ray imaging components, offering innovative solutions in both the medical imaging and industrial x-ray systems sectors. Specializing in the design and manufacture of high-quality x-ray tubes, digital detectors, and comprehensive image processing systems, Varex Imaging plays a pivotal role in enabling accurate diagnostics and effective security measures across various industries.

Core Business and Product Portfolio

The company operates through two primary segments. In the Medical Segment, Varex Imaging focuses on the development, production, and service of components critical for diagnostic processes. This includes a full suite of products such as x-ray tubes, digital detectors, generators, and accessories that consistently meet rigorous performance and safety standards demanded by modern healthcare diagnostics. Equally important is the Industrial Segment, where the company designs and manufactures advanced imaging solutions like Linatron x-ray accelerators, digital flat panel detectors, and high-voltage connectors. These products facilitate essential functions in security screening, industrial inspection, and non-destructive testing while ensuring precise and reliable operation.

Market Position and Global Reach

Varex Imaging has established a strong global presence, with a dominant market share in regions including Europe, the Middle East, and Africa (EMEA), complemented by robust activities in the Americas and Asia Pacific. This widespread reach underscores the company's ability to adapt to diverse regulatory frameworks and meet varying customer requirements across different geographies. The firm's dependable quality and continual innovation have solidified its position as a go-to provider for equipment manufacturers seeking bespoke x-ray imaging solutions.

Technological Innovation and Quality Control

Central to Varex Imaging's operations is a commitment to technological excellence. The company employs advanced engineering techniques and stringent quality control protocols to ensure that every component complies with high-performance standards. Its innovative approach is manifested in the extensive catalog of precision-engineered products that are integral to both diagnostic imaging and security screening. This focus on continuous improvement is supported by substantial research and development efforts aimed at enhancing product efficiency, safety, and reliability.

Operational Excellence and Strategic Differentiation

The company's operational strategy hinges on a deep understanding of industry dynamics. Its product portfolio, marked by technological superiority and an emphasis on customized solutions, sets it apart in a competitive market. Whether catering to the complex demands of modern healthcare diagnostics or addressing the rigorous requirements of industrial inspection systems, Varex Imaging maintains a steadfast commitment to quality and innovation. This dedication not only supports the success of its customers but also reinforces the firm's reputation for delivering robust and high-performance imaging components.

Industry Keywords and Expert Terminology

From the outset, key industry terms like "x-ray imaging components," "medical imaging solutions," and "industrial x-ray systems" underscore the company's expertise. By integrating such terms naturally into the content, the description demonstrates a high level of industry insight and technical proficiency, ensuring that both new and seasoned investors alike gain a clear perspective on the company's operations.

Conclusion

In summary, Varex Imaging Corp stands as an essential contributor to the x-ray imaging sector, with a diverse product offering that spans both medical and industrial applications. Its strategic approach, underpinned by innovative R&D and rigorous quality controls, has enabled the company to maintain its competitive edge in a global marketplace. For anyone seeking a detailed analysis of a firm that underpins vital diagnostic and security imaging technologies, Varex Imaging represents a comprehensive study in precision engineering and operational excellence.

Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) reported its unaudited financial results for Q4 FY21, achieving revenues of $226 million, a 7% sequential increase. The company indicated a strong cash flow of $51 million from operations and improved cash and cash equivalents to $145 million. The non-GAAP net earnings per diluted share were $0.45. For FY21, total revenues reached $818 million with non-GAAP net earnings at $1.31 per diluted share. Guidance for Q1 FY22 anticipates revenues between $200 million and $220 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.96%
Tags
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q4 and full fiscal year 2021 on November 16, 2021, after market close. Following the earnings release, a conference call will take place at 3:00 PM Mountain Time, which will be available via webcast on their website. Investors can also access the call through specific phone numbers. A replay will be offered until November 30. Varex specializes in X-ray imaging components for medical, industrial, and security applications, supported by over 70 years of innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.55%
Tags
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) reported strong financial results for the third quarter of fiscal year 2021, with revenues of $211 million, reflecting a 4% sequential increase and a 23% year-over-year rise, propelled by demand in Medical and Industrial segments. The non-GAAP gross margin improved to 36%, while GAAP operating margin reached 12%. The company generated $22 million in cash flow from operations and strengthened its balance sheet by increasing cash equivalents to $128 million. For the fourth quarter, Varex anticipates revenues between $205 million and $225 million and non-GAAP earnings per share of $0.25 to $0.40.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will release its unaudited financial results for Q3 FY2021 after market close on August 3, 2021. This will be followed by a conference call at 3:00 PM Mountain Time, which will be accessible via the company's website or through designated phone numbers for U.S. and non-U.S. callers. The call will be archived online, with a replay available from August 3rd to August 17th.

Varex specializes in X-ray imaging components, serving medical, industrial, and security sectors, with a workforce of approximately 2,000 globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) has launched the LUMEN 4336W digital radiography detector, enhancing its product line with features prioritizing durability and convenience. This new detector features a robust design with an IP68 rating, ensuring water resistance for real-world applications. It emphasizes reliability through a simplified internal structure and incorporates wireless charging capabilities. Varex continues to guarantee high image quality, leveraging its expertise in X-ray imaging technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.65%
Tags
none
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) announced a partial redemption of $30 million from its $300 million 7.875% senior secured notes due 2027, effective July 15, 2021. The redemption price is set at 103% of the principal amount plus accrued interest since April 15, 2021. CFO Sam Maheshwari highlighted that improved financial performance is enabling debt reduction and decreased interest expenses, indicating a positive cash generation trend for the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
none
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) is set to present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:30 am ET. The company's CFO, Sam Maheshwari, will discuss Varex’s business and future prospects during the presentation. This event will be available via webcast, with replays accessible for 90 days on the company's website, vareximaging.com. Varex, headquartered in Salt Lake City, Utah, specializes in X-ray imaging components used in medical and industrial applications, boasting over 70 years of innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.29%
Tags
conferences
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) reported strong financial performance for 2QFY21, with revenues of $204 million, a 15% sequential increase, and a 3% year-over-year rise. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 35%. Net earnings were $0.08 per diluted share for GAAP and $0.35 for non-GAAP. Positive drivers included robust global sales of CT tubes and industrial digital detectors. Cash flow from operations reached $13 million, and cash and equivalents stood at $111 million by quarter end.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.84%
Tags
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will report its unaudited financial results for Q2 of fiscal year 2021 on May 4, 2021, after market close. A conference call is scheduled for the same day at 3:00 p.m. Mountain Time, accessible through the company's website or via phone. Varex specializes in X-ray imaging components and has over 70 years of innovation, providing solutions for medical, industrial, and security imaging applications. The company employs around 2,000 people globally, reflecting its strong presence in the imaging sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 1:10 pm ET. The company’s CFO, Sam Maheshwari, will discuss Varex’s business and future prospects. The presentation will be webcast and accessible on the company’s website, with replays available for 90 days. Varex specializes in designing and manufacturing X-ray imaging components, playing a crucial role in medical and industrial applications, with over 2,000 employees worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
conferences

FAQ

What is the current stock price of Varex Imaging (VREX)?

The current stock price of Varex Imaging (VREX) is $11.43 as of April 2, 2025.

What is the market cap of Varex Imaging (VREX)?

The market cap of Varex Imaging (VREX) is approximately 470.7M.

What is the primary focus of Varex Imaging Corp?

Varex Imaging Corp is primarily focused on designing and manufacturing critical x-ray imaging components used in both medical diagnostics and industrial applications.

Which business segments does Varex Imaging operate in?

The company operates in two main segments: the Medical Segment, which supplies diagnostic imaging components, and the Industrial Segment, which offers products for security screening and industrial inspection.

What types of products does the Medical Segment provide?

The Medical Segment provides a range of products including x-ray tubes, digital detectors, generators, and various imaging accessories that support high-quality diagnostic imaging.

How does Varex Imaging support industrial imaging applications?

For industrial applications, Varex Imaging designs and manufactures devices such as Linatron x-ray accelerators, digital flat panel detectors, and high-voltage connectors, facilitating precise screening and inspection processes.

In which regions does Varex Imaging have significant market reach?

Varex Imaging enjoys a strong global presence with major market activity in the EMEA region, alongside significant operations in the Americas and Asia Pacific.

How does the company ensure product quality and reliability?

The company employs advanced engineering techniques and stringent quality assurance protocols in its manufacturing processes to ensure that every product meets the high standards required for critical imaging applications.

What distinguishes Varex Imaging from its competitors?

Its extensive, technically advanced product portfolio, combined with a commitment to innovation and customized solutions, allows Varex Imaging to consistently support the complex needs of its customers in both the medical and industrial sectors.

How important is technological innovation to Varex Imaging?

Technological innovation is central to the company’s strategy, with continuous research and development efforts that drive improvements in product design, efficiency, and reliability.
Varex Imaging Corp

Nasdaq:VREX

VREX Rankings

VREX Stock Data

470.65M
40.50M
1.7%
97.32%
2.34%
Medical Devices
Electronic Components, Nec
Link
United States
SALT LAKE CITY